SHARE

KKR and Warburg Pincus bid for Gerresheimer

The consortium has reportedly submitted a non-binding bid for Gerresheimer AG, which makes pens for weight loss injection drugs. The bid values the company at nearly €3.1bn, but the takeover isn’t guaranteed. The private equity funds have not commented.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.